Specimen Stabilizing Solution
Solution to retard the generation of complement activation fragments and complexes in human serum and plasma during processing and storage
Product Specifications
| Citations | 0 |
|---|---|
| Description | Solution to retard the generation of complement activation fragments and complexes in human serum and plasma during processing and storage |
| Storage | Storage: 2°C to 8°C |
| Form | Frozen Liquid |
| Concentration | Refer to certificate of analysis |
| Applications | See citations and technical data sheet for application info. |
Ordering Information
| Catalog Number | A9576 |
|---|---|
| Catalog Number (CE) | N/A |
| Size | 25 mL |
| Price (USD) | $195.00 |
| Price (EURO) | 170,00 € |
Contact us
| US Phone | +1 (858) 552 1100 |
|---|---|
| EU Phone | +353 (91) 412 474 |
| US Email | contact-us@quidelortho.com |
| EU Email | contact-emea@quidelortho.com |
- Specifications
- Citations
- Certificate of Analysis
Specifications
| Description | Solution to retard the generation of complement activation fragments and complexes in human serum and plasma during processing and storage |
|---|---|
| Size | 25 mL |
| Storage | Storage: 2°C to 8°C |
| Form | Frozen Liquid |
| Concentration | Refer to certificate of analysis |
| Applications | See citations and technical data sheet for application info. |
| Purity | Refer to certificate of analysis |
| Source | Refer to certificate of analysis |
| Activity | Refer to certificate of analysis |
| Molecular Weight | N/A |
| Background | The QuidelOrtho Specimen Stabilizing Solution, when used in accordance with the procedure described below, will retard the generation of complement activation fragments and complexes in human serum and plasma during processing and storage. This product extends the stability of the specimens significantly reducing the likelihood of in vitro generated elevation of complement fragments. The Quidel Specimen Stabilizing Solution should be used for stabilizing serum and plasma specimens that cannot be tested or stored at or below –70°C, within four hours after phlebotomy. The Quidel Specimen Stabilizing Solution is intended for use with all assays designed to assess complement activation fragments, specifically the MicroVue™ iC3b, C3a, C4d, Bb Plus and SC5b-9 Plus EIA kits. |
Citations
| Title | Year | Applications | Sample Species | Sample | Sample Details |
|---|
Certificate of Analysis
